H. Mine

发表

The First Large‐Scale Nucleic Acid Amplification Testing (NAT) of Donated Blood Using Multiplex Reagent for Simultaneous Detection of HBV, HCV, and HIV‐1 and Significance of NAT for HBV

K. Nishioka, T. Hirose, T. Tanaka, 2001, Microbiology and immunology.

Nucleotide sequence of a new DRB1*15 variant, 1505, in a Japanese family.

M. Nakagawa, K. Tsuboyama, N. Yamagata, 1995, Tissue antigens.

Genetic contribution of the tumor necrosis factor region in guillain‐barré syndrome

H. Kawakami, M. Nishimura, T. Uchiyama, 1998, Annals of neurology.

Tumor necrosis factor, tumor necrosis factor receptors type 1 and 2, lymphotoxin-alpha, and HLA-DRB1 gene polymorphisms in human T-cell lymphotropic virus type I associated myelopathy.

M. Matsuoka, H. Kawakami, M. Nishimura, 2000, Human immunology.

An HLA-B null allele (B*1526N) with a stop codon in exon 3 generated by a point mutation.

K. Tokunaga, T. Juji, Y. Ishikawa, 1997, Tissue antigens.

High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan.

K. Nishioka, A. Yoshikawa, H. Murokawa, 2003, Journal of virological methods.

Epidemiology of blood donors in Japan, positive for hepatitis B virus and hepatitis C virus by nucleic acid amplification testing

K. Tadokoro, A. Yoshikawa, H. Ohnuma, 2005, Vox sanguinis.

HLAs and genes in Japanese patients with multiple sclerosis: evidence for increased frequencies of HLA-Cw3, HLA-DR2, and HLA-DQB1*0602.

H. Inoko, H. Kawakami, E. Maruya, 1992, Human immunology.

HLA-DRB1 and tumor necrosis factor gene polymorphisms in Japanese patients with multiple sclerosis

H. Kawakami, H. Saji, M. Nishimura, 1998, Journal of Neuroimmunology.

Status of NAT screening for HCV, HIV and HBV: experience in Japan.

K. Nishioka, A. Yoshikawa, H. Ohnuma, 2002, Developments in biologicals.